Methuselah is smiling!
A LinkGevity motto "Pioneering Anti-Necrotics™"
"A UK start-up has designed a drug to slow aging by preventing necrosis — early cell death in response to injury or illness. LinkGevity says that its drug Link-001 has prevented necrosis in lab-grown models of human organs, by stopping the flow of calcium ions into cells. The company plans to test its anti-necrosis drug in people with damaged kidneys later this year, if it can win regulatory approval. Link-001 is a combination of two already-approved drugs, which LinkGevity hopes will help it move into the clinic quickly. To date, no longevity drugs have been approved because of debate over the underlying mechanisms of aging and relevant biomarkers."
Start-up takes aim at ageing with drug to block cell death (behind paywall)
But the company's pipelines are kept very vague. Secrecy or?
The beautiful mind behind this longevity research: Dr. Carina Kern, CEO of LinkGevity
No comments:
Post a Comment